BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32492308)

  • 21. Intracranial phosphaturic mesenchymal tumors: report of 2 cases.
    Mathis DA; Stehel EJ; Beshay JE; Mickey BE; Folpe AL; Raisanen J
    J Neurosurg; 2013 Apr; 118(4):903-7. PubMed ID: 23350780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A paranasal tumor associated with tumor-induced osteomalacia.
    Inokuchi G; Tanimoto H; Ishida H; Sugimoto T; Yamauchi M; Miyauchi A; Nibu K
    Laryngoscope; 2006 Oct; 116(10):1930-3. PubMed ID: 17003734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor-induced osteomalacia: a case report.
    Romualdo-Silva DD; Silva BC; Caetano CV; Tibúrcio AM; Nunes MB; Chagas SA; Polito ET; Ferreira AR; Purisch S
    Arq Bras Endocrinol Metabol; 2009 Apr; 53(3):378-82. PubMed ID: 19578602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncogenic osteomalacia associated with phosphaturic mesenchymal tumour, mixed connective tissue type of the knee.
    Szumera-Ciećkiewicz A; Ptaszyński K; Pawełas A; Rutkowski P
    Pol J Pathol; 2009; 60(4):193-8. PubMed ID: 20200786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Tumor-induced osteomalacia in a patient with a phosphaturic mesenchymal tumor revealing feature of an ossifying fasciitis of the left abdominal wall].
    Oba K; Takei A; Natori S; Arai K; Nakanishi K; Oda Y
    Nihon Naika Gakkai Zasshi; 2002 Jun; 91(6):1870-2. PubMed ID: 12170756
    [No Abstract]   [Full Text] [Related]  

  • 26. Phosphaturic mesenchymal tumour-mixed connective tissue variant without oncogenic osteomalacia.
    Winters R; Bihlmeyer S; McCahill L; Cooper K
    J Clin Pathol; 2009 Aug; 62(8):760-1. PubMed ID: 19638551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor-induced osteomalacia.
    Kaul M; Silverberg M; Dicarlo EF; Schneider R; Bass AR; Erkan D
    Clin Rheumatol; 2007 Sep; 26(9):1575-9. PubMed ID: 17225058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Detection of the primary tumor site in tumor-induced osteomalacia by indium-111 octreotide scintigraphy: a case report].
    Takahashi M; Toru S; Ota K; Izumiyama H; Yokota T; Mizusawa H
    Rinsho Shinkeigaku; 2008 Feb; 48(2):120-4. PubMed ID: 18326305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. August 2003: 47-year-old female with a 7-year history of osteomalacia and hypophosphatemia.
    Reis-Filho JS; Paiva ME; Lopes JM
    Brain Pathol; 2004 Jan; 14(1):111-2, 115. PubMed ID: 14997944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Tumor-induced rickets/osteomalacia].
    Fukumoto S
    Nihon Rinsho; 2006 Jun; Suppl 2():96-9. PubMed ID: 16817359
    [No Abstract]   [Full Text] [Related]  

  • 31. Paraneoplastic Secretion of Multiple Phosphatonins From a Deep Fibrous Histiocytoma Causing Oncogenic Osteomalacia.
    Leow MKS; Dogra S; Ge X; Chuah KL; Liew H; Loke KSH; McFarlane C
    J Clin Endocrinol Metab; 2021 Apr; 106(5):e2299-e2308. PubMed ID: 33462615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and bone density outcomes of tumor-induced osteomalacia after treatment.
    Umphrey LG; Whitaker MD; Bosch EP; Cook CB
    Endocr Pract; 2007 Sep; 13(5):458-62. PubMed ID: 17872346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acquired hypophosphatemic osteomalacia associated with multiple myeloma.
    Narvaez J; Domingo-Domenech E; Narvaez JA; Nolla JM; Valverde J
    Joint Bone Spine; 2005 Oct; 72(5):424-6. PubMed ID: 16112595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor-induced osteomalacia associated with a maxillofacial tumor producing fibroblast growth factor 23: report of a case and review of the literature.
    Mori Y; Ogasawara T; Motoi T; Shimizu Y; Chikazu D; Tamura K; Fukumoto S; Takato T
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):e57-63. PubMed ID: 20219587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Osteomalacia of mesenchymatous tumors. Apropos of a new case].
    Lejeune E; Bouvier M; Meunier P; Vauzelle JL; Deplante JP; David L; Llorca G; André-Fouet E
    Rev Rhum Mal Osteoartic; 1979 Mar; 46(3):187-93. PubMed ID: 472647
    [No Abstract]   [Full Text] [Related]  

  • 36. Bone scintigraphy in a case of oncogenous osteomalacia.
    Ohta H; Nakaishi S; Oki S; Simizu M; Watanabe H; Fujikawa S; Nakade M; Watanabe H; Kohno K; Shintaku M
    Clin Nucl Med; 1998 Jul; 23(7):467-9. PubMed ID: 9676956
    [No Abstract]   [Full Text] [Related]  

  • 37. [Tumor-associated hypophosphatemic osteomalacia: case report and literature review].
    Ewerbeck V; Simank HG; Krempien B
    Z Orthop Ihre Grenzgeb; 1994; 132(6):491-6. PubMed ID: 7831951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumour-induced osteomalacia: a literature review and a case report.
    Dadoniene J; Miglinas M; Miltiniene D; Vajauskas D; Seinin D; Butenas P; Kacergius T
    World J Surg Oncol; 2016 Jan; 14(1):4. PubMed ID: 26744291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diffuse pain, hypophosphatemia, and a subcutaneous nodule.
    Dewitt CA; Collins MT; Cowen EW
    J Am Acad Dermatol; 2007 Sep; 57(3):509-12. PubMed ID: 17707153
    [No Abstract]   [Full Text] [Related]  

  • 40. Sinonasal phosphaturic mesenchymal tumor (mixed connective tissue variant): report of 2 cases.
    Shelekhova KV; Kazakov DV; Michal M
    Am J Surg Pathol; 2010 Apr; 34(4):596-7. PubMed ID: 20216375
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.